Epitopea is a company founded in 2022 headquartered in Canada. Brouky records 3 investors associated with the company.
Epitopea is a transatlantic cancer immunotherapeutics company based in Montreal, Canada and Cambridge, UK. It develops off-the-shelf RNA-based cancer immunotherapies targeting shared aberrantly expressed tumour-specific antigens using its proprietary CryptoMap platform.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.